Is anyone by chance on the Boven 3-agent trial at Sloan Kettering? It involves BGB31-11(Zanabrutinib), Gazyva and Venetoclax?
Thanks
Is anyone by chance on the Boven 3-agent trial at Sloan Kettering? It involves BGB31-11(Zanabrutinib), Gazyva and Venetoclax?
Thanks
I heard of it. Dr Mato mentioned it to us. It sounds like a smart combination hedging all your bets. I would find out about the efficacy of zanutibrutinib versus IB?